Toward precision risk stratification: predicting in-hospital death in sepsis patients with MRSA bacteremia

迈向精准风险分层:预测脓毒症合并耐甲氧西林金黄色葡萄球菌菌血症患者的院内死亡率

阅读:2

Abstract

Patients with sepsis and concurrent methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection face a substantial risk of mortality. This study aimed to develop and validate a pragmatic, interpretable prediction model for in-hospital mortality in this high-risk population. We conducted a retrospective, single-center cohort study including 1,605 eligible patients, who were randomly divided into a training set (n = 1,124) and a validation set (n = 481). A rigorous, multi-stage feature selection pipeline—integrating univariate analysis, multi-model machine learning importance assessment, the Boruta algorithm, and stability selection via LASSO—was applied to 64 candidate variables. This process identified seven parsimonious, clinically accessible predictors: Glasgow Coma Scale score, minimum pH, maximum blood urea nitrogen, minimum white blood cell count, minimum platelet count, maximum lactate level, and the presence of pneumonia. Among six compared machine learning algorithms, logistic regression was selected for its optimal balance of performance and inherent interpretability. The final model demonstrated strong discriminative ability, with an area under the receiver operating characteristic curve (AUC) of 0.861 (95% CI: 0.840–0.882) in the training set and 0.844 (95% CI: 0.811–0.877) in the independent validation set, and showed good calibration (Hosmer-Lemeshow test p = 0.274). Decision curve analysis confirmed superior clinical net benefit across a wide range of risk thresholds. The model maintained robust and equitable performance across key patient subgroups and exhibited stability in extensive sensitivity analyses, including multiple imputation and bootstrap internal validation. This interpretable, seven-variable logistic regression model provides a clinically actionable tool for early mortality risk stratification, potentially supporting timely and tailored intervention strategies for sepsis patients with MRSA bacteremia. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12879-026-12584-4.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。